Detection of multiple macrolide- and lincosamide-resistant strains of Streptococcus pyogenes from patients in the Boston area

被引:32
作者
Hasenbein, ME
Warner, JE
Lambert, KG
Cole, SE
Onderdonk, AB
McAdam, AJ
机构
[1] Childrens Hosp, Dept Lab Med, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Boston, MA 02115 USA
[3] Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA
关键词
D O I
10.1128/JCM.42.4.1559-1563.2004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Macrolide (including erythromycin and azithromycin) and lincosamide (including clindamycin) antibiotics are recommended for treatment of penicillin-allergic patients with Streptococcus pyogenes pharyngitis. Resistance to erythromycin in S. pyogenes can be as high as 48% in specific populations in the United States. Macrolide and lincosamide resistance in S. pyogenes is mediated by several different genes. Expression of the erm(A) or erm(B) genes causes resistance to erythromycin and inducible or constitutive resistance to clindamycin, respectively, whereas expression of the mef(A) gene leads to resistance to erythromycin but not clindamycin. We studied the resistance of S. pyogenes to erythromycin and clindamycin at an urban tertiary-care hospital. Of 196 sequential isolates from throat cultures, 15 (7.7%) were resistant to erythromycin. Three of these were also constitutively resistant to clindamycin and had the erm(B) gene. Five of the erythromycin-resistant isolates were resistant to clindamycin upon induction with erythromycin and had the erm(A) gene. The remaining seven erythromycin-resistant isolates were susceptible to clindamycin even upon induction with erythromycin and had the mef(A) gene. Pulsed-field gel electrophoresis analysis and emm typing demonstrated that the erythromycin-resistant S. pyogenes comprised multiple strains. These results demonstrate that multiple mechanisms of resistance to macrolide and lincosamide antibiotics are present in S. pyogenes strains in the United States.
引用
收藏
页码:1559 / 1563
页数:5
相关论文
共 30 条
[1]   Sequencing emm-specific PCR products for routine and accurate typing of group a streptococci [J].
Beall, B ;
Facklam, R ;
Thompson, T .
JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (04) :953-958
[2]   Pulsed-field gel electrophoresis is more discriminating than multilocus enzyme electrophoresis and random amplified polymorphic DNA analysis for typing pyogenic streptococci [J].
Bert, F ;
Branger, C ;
LambertZechovsky, N .
CURRENT MICROBIOLOGY, 1997, 34 (04) :226-229
[3]   Antimicrobial susceptibility profile among β-haemolytic Streptococcus spp. collected in the SENTRY Antimicrobial Surveillance Program -: North America, 2001 [J].
Biedenbach, DJ ;
Stephen, JM ;
Jones, RN .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2003, 46 (04) :291-294
[4]   Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis [J].
Bisno, AL ;
Gerber, MA ;
Gwaltney, JM ;
Kaplan, EL ;
Schwartz, RH .
CLINICAL INFECTIOUS DISEASES, 2002, 35 (02) :113-125
[5]   Antimicrobial resistance amongst isolates of Streptococcus pyogenes and Staphylococcus aureus in the PROTEKT antimicrobial surveillance programme during 1999-2000 [J].
Cantón, R ;
Loza, E ;
Morosini, MI ;
Baquero, F .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 50 :9-24
[6]  
CHUGN WO, 1999, J ANTIMICROB CHEMOTH, V43, P5
[7]   Molecular cloning and functional analysis of a novel macrolide-resistance determinant, mefA, from Streptococcus pyogenes [J].
Clancy, J ;
Petitpas, J ;
DibHajj, F ;
Yuan, W ;
Cronan, M ;
Kamath, AV ;
Bergeron, J ;
Retsema, JA .
MOLECULAR MICROBIOLOGY, 1996, 22 (05) :867-879
[8]   IN-VITRO SUSCEPTIBILITY OF RECENT NORTH-AMERICAN GROUP-A STREPTOCOCCAL ISOLATES TO 11 ORAL ANTIBIOTICS [J].
COONAN, KM ;
KAPLAN, EL .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1994, 13 (07) :630-635
[9]   Prevalence and mechanisms of macrolide resistance in clinical isolates of group A streptococci from Ontario, Canada [J].
De Azavedo, JCS ;
Yeung, RH ;
Bast, DJ ;
Duncan, CL ;
Borgia, SB ;
Low, DE .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (09) :2144-2147
[10]   Prevalence and mechanisms of macrolide resistance in invasive and noninvasive group B streptococcus isolates from Ontario, Canada [J].
de Azavedo, JCS ;
McGavin, M ;
Duncan, C ;
Low, DE ;
McGeer, A .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (12) :3504-3508